Setsuo Takeda

1.1k total citations
41 papers, 991 citations indexed

About

Setsuo Takeda is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Setsuo Takeda has authored 41 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Oncology and 12 papers in Organic Chemistry. Recurrent topics in Setsuo Takeda's work include Colorectal Cancer Treatments and Studies (8 papers), Synthesis and Reactions of Organic Compounds (6 papers) and Biochemical and Molecular Research (5 papers). Setsuo Takeda is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Synthesis and Reactions of Organic Compounds (6 papers) and Biochemical and Molecular Research (5 papers). Setsuo Takeda collaborates with scholars based in Japan. Setsuo Takeda's co-authors include Norio Unemi, Junji Uchida, A Fujioka, Hirofumi Satake, K Nakano, Tetsuhiko Shirasaka, Hitoshi Saitô, Hiromi Okabe, M Fukushima and Teiji Takechi and has published in prestigious journals such as Journal of Medicinal Chemistry, Cancer Letters and The Journal of Steroid Biochemistry and Molecular Biology.

In The Last Decade

Setsuo Takeda

39 papers receiving 969 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Setsuo Takeda Japan 14 575 367 347 145 92 41 991
Norio Unemi Japan 16 503 0.9× 315 0.9× 308 0.9× 121 0.8× 69 0.8× 49 920
Hisanobu Niitani Japan 18 654 1.1× 578 1.6× 358 1.0× 93 0.6× 55 0.6× 65 1.1k
Katsumi Nakatomi Japan 18 971 1.7× 320 0.9× 708 2.0× 101 0.7× 115 1.3× 58 1.4k
G G Chabot France 15 1.0k 1.8× 169 0.5× 915 2.6× 115 0.8× 92 1.0× 24 1.4k
Isabelle Hennebelle France 19 726 1.3× 188 0.5× 506 1.5× 91 0.6× 106 1.2× 25 1.1k
Hitoshi Arioka Japan 18 504 0.9× 166 0.5× 588 1.7× 87 0.6× 129 1.4× 60 1.1k
Ken Shiozawa Japan 16 861 1.5× 107 0.3× 687 2.0× 174 1.2× 52 0.6× 24 1.3k
Kenneth Steadman United States 16 611 1.1× 160 0.4× 543 1.6× 92 0.6× 101 1.1× 28 1.1k
Seiji Doi Japan 12 511 0.9× 177 0.5× 365 1.1× 64 0.4× 58 0.6× 20 737
N Saijo Japan 15 531 0.9× 230 0.6× 425 1.2× 60 0.4× 85 0.9× 48 877

Countries citing papers authored by Setsuo Takeda

Since Specialization
Citations

This map shows the geographic impact of Setsuo Takeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Setsuo Takeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Setsuo Takeda more than expected).

Fields of papers citing papers by Setsuo Takeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Setsuo Takeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Setsuo Takeda. The network helps show where Setsuo Takeda may publish in the future.

Co-authorship network of co-authors of Setsuo Takeda

This figure shows the co-authorship network connecting the top 25 collaborators of Setsuo Takeda. A scholar is included among the top collaborators of Setsuo Takeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Setsuo Takeda. Setsuo Takeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakahira, Shin, Shoji Nakamori, Masanori Tsujie, et al.. (2008). Pretreatment with S-1, an oral derivative of 5-fluorouracil, enhances gemcitabine effects in pancreatic cancer xenografts.. PubMed. 28(1A). 179–86. 26 indexed citations
2.
Tsujie, Masanori, Shoji Nakamori, Shin Nakahira, et al.. (2006). Schedule-dependent Therapeutic Effects of Gemcitabine Combined with Uracil-Tegafur in a Human Pancreatic Cancer Xenograft Model. Pancreas. 33(2). 142–147. 12 indexed citations
3.
Takeda, Setsuo, et al.. (2000). .ALPHA.,.ALPHA.-gem-Difluorination of .ALPHA.-(Alkylthio)acetophenone Derivatives with N-Fluoropyridinium Salts.. Chemical and Pharmaceutical Bulletin. 48(7). 1097–1100. 6 indexed citations
4.
Uchida, Junji, Koji Sato, Hiroyuki Okabe, et al.. (2000). Experimental postoperative adjuvant chemotherapy by UFT using primary tumor amputation model.. International Journal of Molecular Medicine. 5(4). 357–62. 3 indexed citations
5.
Tada, Yukio, et al.. (1996). Synthesis and Antitumor Activities of 5'-O-Aminoacyl-3'-O-benzyl Derivatives of 2'-Deoxy-5-fluorouridine and Related Compounds.. Chemical and Pharmaceutical Bulletin. 44(1). 150–155. 2 indexed citations
6.
Nukatsuka, Mamoru, Akio Fujioka, Hitoshi Saitô, et al.. (1996). Prolongation of survival period and improvement of cancer cachexia by long term administration of UFT. Cancer Letters. 104(2). 197–203. 5 indexed citations
7.
Yoshida, Masahiko, Takashi Kobunai, Kousuke Nakano, et al.. (1996). Prediction of the optimum clinical dosing schedule for menogaril from results with tumor-bearing mice.. PubMed. 16(5A). 2869–73. 1 indexed citations
8.
Fujimoto, Katsuhiko, Makoto Nomura, Jun‐ichi Yamashita, et al.. (1993). Antitumor Agents. II. Regio- and Stereospecific Syntheses of 1-.BETA.-Alkyl-1-desoxypodophyllotoxin Derivatives and Biological Activity.. Chemical and Pharmaceutical Bulletin. 41(5). 907–912. 12 indexed citations
9.
Fujimoto, Katsuhiko, Makoto Nomura, Jun‐ichi Yamashita, et al.. (1992). Antitumor Agents. I. DNA Topoisomerase II Inhibitory Activity and the Structural Relationship of Podophyllotoxin Derivatives as Antitumor Agents.. Chemical and Pharmaceutical Bulletin. 40(10). 2720–2727. 31 indexed citations
10.
Takeda, Setsuo, Jun‐ichi Yamashita, Hiroshi Matsumoto, et al.. (1992). Potentiation of the antitumor activity of 5-trifluoromethyl-2?-deoxyuridine by the use of depot forms of the parent compound. Cancer Chemotherapy and Pharmacology. 30(5). 360–364. 4 indexed citations
11.
Matsuo, Kenichi, Jiro Shibata, Mamoru Nukatsuka, et al.. (1992). Interaction of DP-TAT-59, an active metabolite of new triphenylethylene-derivative (TAT-59), with estrogen receptors. The Journal of Steroid Biochemistry and Molecular Biology. 43(6). 507–514. 6 indexed citations
12.
Takeda, Setsuo, Jun‐ichi Yamashita, Hitoshi Saitô, et al.. (1991). Antitumor activity of FTC-092, a masked 5-trifluoromethyl-2?-deoxyuridine derivative. Cancer Chemotherapy and Pharmacology. 29(2). 122–126.
13.
Sugimoto, Yoshikazu, et al.. (1990). TAT-59, a new triphenylethylene derivative with antitumor activity against hormone-dependent tumors. European Journal of Cancer and Clinical Oncology. 26(3). 397–404. 31 indexed citations
14.
Wierzba, Konstanty, et al.. (1990). Menogaril, an Anthracycline Compound with a Novel Mechanism of Action: Cellular Pharmacology. Japanese Journal of Cancer Research. 81(8). 842–849. 7 indexed citations
15.
Yamashita, Jun‐ichi, et al.. (1989). Studies on antitumor agents. 8. Antitumor activities of O-alkyl derivatives of 2'-deoxy-5-(trifluoromethyl)uridine and 2'-deoxy-5-fluorouridine. Journal of Medicinal Chemistry. 32(1). 136–139. 22 indexed citations
16.
Fujita, Tetsuro, Yoshio Takeda, Sun H, et al.. (1988). Cytotoxic and Antitumor Activities ofRabdosiaDiterpenoids. Planta Medica. 54(5). 414–417. 60 indexed citations
17.
Yamashita, Jun‐ichi, et al.. (1987). Studies on antitumor agents. VI. Syntheses and antitumor activities of acyl derivatives of 2'-deoxy-5-trifluoromethyluridine.. Chemical and Pharmaceutical Bulletin. 35(5). 2090–2094. 5 indexed citations
18.
Unemi, Norio & Setsuo Takeda. (1981). Studies on combination therapy with 1-(tetrahydro-2-furanyl)-5-fluorouracil plus uracil II. Effects of uracil on in vitro metabolisms of 1-(tetrahydro-2-furanyl)-5-fluorouracil and 5-fluorouracil.:Effects of Uracil on In vitro Metabolisms of 1-(Tetrahydro-2-furanyl)-5-fluorouracil and 5-Fluorouracil. Chemotherapy. 29(2). 176–184. 9 indexed citations
19.
20.
Unemi, Norio, et al.. (1981). STUDIES ON COMBINATION THERAPY WITH 1-(TETRAHYDRO-2-FURANYL)-5-FLUOROURACIL PLUS URACIL. II. Chemotherapy. 29(2). 164–175. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norio Unemi Breakdown of academic impact, for papers by Hisanobu Niitani Breakdown of academic impact, for papers by Katsumi Nakatomi Breakdown of academic impact, for papers by G G Chabot Breakdown of academic impact, for papers by Isabelle Hennebelle Breakdown of academic impact, for papers by Hitoshi Arioka Breakdown of academic impact, for papers by Ken Shiozawa Breakdown of academic impact, for papers by Kenneth Steadman Breakdown of academic impact, for papers by Seiji Doi Breakdown of academic impact, for papers by N Saijo
Rankless by CCL
2026